![Donna Haire](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Donna Haire
Geschäftsführer bei
FLUOGUIDE A/S
Profil
Donna Haire is currently Chief Executive Officer & Director at Eriah Group, Inc. Current roles also include Director at Bioporto.
A starting in 2025, Director at Sedana Medical AB starting in 2024, and Chief Operating Officer at FluoGuide A starting in 2025.
Former positions include SVP-Regulatory, Clinical & Medical Affairs at AngioDynamics, Inc. from 2011 to 2012, VP & Head-Medical Care & Global Regulatory Affairs at Bayer AB from 2013 to 2018, and Executive Vice President-Regulatory & Quality at On Target Laboratories LLC.
Education includes graduate studies at Cleveland State University and undergraduate studies at the University of Akron.
Aktive Positionen von Donna Haire
| Unternehmen | Position | Beginn |
|---|---|---|
| SEDANA MEDICAL AB | Direktor/Vorstandsmitglied | 01.01.2024 |
| FLUOGUIDE A/S | Geschäftsführer | 24.11.2025 |
| BIOPORTO A/S | Direktor/Vorstandsmitglied | 11.04.2025 |
Ehemalige bekannte Positionen von Donna Haire
| Unternehmen | Position | Ende |
|---|---|---|
Bayer AB
 Bayer AB Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | General Counsel | 01.01.2018 |
| ANGIODYNAMICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2012 |
On Target Laboratories LLC
 On Target Laboratories LLC BiotechnologyHealth Technology Discovers, develops and commercializes small molecules that target pathological cells | Corporate Officer/Principal | - |
Ausbildung von Donna Haire
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
52
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Bioporto A/S
 Bioporto A/S Medical SpecialtiesHealth Technology Develops and markets human and animal neutrophil gelatinase-associated lipocalin antibodies kits | Health Technology |
AngioDynamics, Inc.
 AngioDynamics, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices used by radiologists, vascular surgeons and other physicians | Health Technology |
Cleveland State University
 Cleveland State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Akron
 University of Akron Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer AB
Bayer AB Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
On Target Laboratories LLC
On Target Laboratories LLC BiotechnologyHealth Technology Discovers, develops and commercializes small molecules that target pathological cells | Health Technology |
Sedana Medical AB
 Sedana Medical AB Medical SpecialtiesHealth Technology Develops and wholesales medical devices and drugs | Health Technology |
FluoGuide A/S
 FluoGuide A/S Pharmaceuticals: MajorHealth Technology Engages in the development of drugs used for the improvement of surgical outcomes by making cancer fluorescent | Health Technology |
